Skip Navigation

U.S. Department of Health & Human Services
Navigation to Home, Contact Us, Site Map, About REMM
Radiation Event Medical Management (REMM)
REMM Banner
Search REMM Web Site
What Kind of Emergency? Initial Event Activities Patient Management Algorithms Management Modifiers Tools & Guidelines

REMM Home Contact Us Site Map About REMM
 

You are here: Home > Dose Estimator for Exposure: 3 Biodosimetry Tools > About Dicentric Chromosome Assays


About Dicentric Chromosome Assays


Warning: cautions and limitations


  • Few laboratories have sufficient experience with the rigorous quality control and dose calibration necessary to perform this assay when it is used to estimate radiation absorbed dose.
  • REMM specifically recommends against clinicians using results from non-reference laboratories for making clinical decisions in a radiation event.
  • Dicentric Chromosome Assay results reported from radiation reference laboratories will include an estimated radiation dose, not just a count of dicentric chromosomes. This result can be useful in clinical decision-making along with other clinical (signs and symptoms) and laboratory data in order to triage and manage patients with whole body or partial body radiation exposure.
    (See exposure algorithm)
  • Major US government laboratories with experience performing radiation event related dicentric chromosome assays include
    • Armed Forces Radiobiology Research Institute
      http://www.afrri.usuhs.mil/
      8901 Wisconsin Avenue
      Bethesda, MD 20889-5603
      Contact Security in Emergencies: 1-301-295-0530
      Medical Radiology Advisory Team: 1-301-295-0316
    • Oak Ridge Institute for Science and Education, Radiation Emergency Assistance Center/Training Site (REAC/TS)
      Cytogenetic Biodosimetry Laboratory
      http://orise.orau.gov/reacts/cytogenetics-lab.htm
      (Video: http://orise.orau.gov/video/reacts/cytolab.htm)
      Attn: Dr. Doran Christensen/Dr. Gordon Livingston
      P.O. Box 117, MS 39
      Oak Ridge, TN 37831-0117
      Emergency: DOE/ORO: 1-865-576-1005 (ask for REAC/TS), this is also the after hours number
      At other times: 1-865-576-3131 (between 8:30-4:30 CST)
      Download a brochure (PDF - 280 KB)

top of page


Background information


  • Illustrations of normal chromosome and dicentric chromosome
  • Dicentric Chromosome Assay is based on the principle that radiation exposure causes DNA strand breaks, in particular double strand breaks.
    • During repair of DNA strand breaks, misrepair of 2 chromosomes and abnormal chromosome replication can lead to dicentric chromosomes, that is, a chromosome with 2 centromeres.
    • Increases in radiation dose produce increasing numbers of dicentric chromosomes.
    • Although radiation induces many types of chromosomal changes in addition to dicentric chromosomes, dicentrics are considered the most sensitive and most specific for assessing radiation dose.
  • Factors that influence the results of Dicentric Chromosome Assay include
    • Total dose
    • Dose rate
    • Percent body irradiated (whole vs. partial body)
    • Radiation quality (e.g., photon vs. neutron)
    • Sampling time after exposure
      • Optimal time for sample collection: between 24 hours and about 4-6 weeks post-exposure
      • Specimens drawn after 6 weeks can be analyzed using time correction factors.
  • Dicentric Chromosome Assay is 2
    • Time consuming and highly technique dependent
    • Very specific for radiation
      • Background level for dicentrics in the population is low, about 1 dicentric chromosome in 1,000 cells
      • Few chemicals (except those which are "radiomimetics") cause dicentrics.
    • Very sensitive for radiation
      • Threshold dose as low as about 0.05 Gy may be identified by this assay.
      • There is a good dose-effect relationship in the range of 0.05 Gy to 5.0 Gy for acute exposures to low linear energy transfer (LET) radiation 2
      • The Dicentric Chromosome Assay is both specific and sensitive for radiation exposure even at low doses.
  • Use of this assay after a large mass casualty event
    • After a large radiation event, senior event managers may provide information about approved reference laboratories available to analyze specimens.
    • Dose estimation from the Dicentric Chromosome Assay, even from reference laboratories, should be used in conjunction with all other clinical (signs and symptoms) and laboratory information in order to triage and manage patients with significant radiation exposure.
    • Clinicians may have difficulty obtaining assay results becuase of
      • Limited national laboratory capacity
      • Time to receive assay results is typically at least 3-4 days after sample is received.
  • Overview of methods 2
    • Peripheral blood is obtained from individuals potentially exposed to radiation.
    • Lymphocytes are stimulated to grow in culture and cells in first-division metaphase spreads are collected on glass slides.
    • Cells with chromosomes in the metaphase stage of division are stained and analyzed for chromosome aberrations.
    • Dose estimates are made by
      • Counting the frequency of dicentrics in the sample
      • Comparing the frequency of dicentrics counted to calibration curves reflecting radiation quality, e.g., 250 kVp x rays, fission neutrons, and Cobalt-60 gamma rays 3 (See Figure)
  • Significant laboratory expertise with performing the Dicentric Chromosome Assay for clinical use in dose estimation is crucial.
    • Reference laboratory intercomparisons for quality assurance should be done periodically.
    • Calibration curves can vary slightly even among reference laboratories.
    • An important study comparing results from multiple reference laboratories has been published. 4
  • Scoring 1
    • Metaphase counting (scoring) of dicentrics is performed on a representative sample of cultured lymphocytes.
      • As few as 20 metaphases from peripheral blood lymphocytes may indicate confirmation of an exposure.
      • Counting 20 metaphases facilitates more rapid analysis, as after a mass casualty event.
      • Scoring 50 metaphases provides a more accurate result than scoring 20.
      • Where there is disagreement with initial assessments or evidence of significantly inhomogeneous exposure, resolution may be provided by increasing the number of scored metaphases from 20 to 50, and then to as many as 500 or 1,000. Scoring this large number requires a significantly longer period of time.
    • Scored metaphase samples showing an inhomogeneous number of dicentrics per cell provides evidence for partial-body exposure. 5
  • When to draw blood for the dicentric chromosome assay 1
    • Optimal time is at least 24 hours after exposure.
      • Dicentrics are formed by a misrepair of 2 chromosomes
      • 24 hours allows sufficient time to permit completion of repair by lymphocytes
      • For suspected doses > 4 Gy, AFRRI suggests drawing blood at 1-6 hours post-event in order to obtain a sufficient population of lymphocytes. After 6 hours the peripheral blood may be depleted of lymphocytes.
      • NOTE: Drawing blood 1-6 hours after an event may not be possible in a mass casualty situation.
    • Samples drawn within 4-6 weeks after exposure
      • Valid results do not require correction for sampling delay relative to the half-life of circulating lymphocytes in peripheral blood.
    • Samples drawn >6 weeks after exposure
      • Valid results require application of a correction factor to account for the lymphocyte life span in circulating blood.
      • Unstable aberrations (primarily dicentric and ring forms) are eliminated over time, decreasing assay sensitivity.
    • Samples drawn between 6 - 12 months after exposure
      • Can be used to estimate doses > 0.5 Gy (acute photon exposure), if appropriate corrections are made.
  • Use of dicentric chromosome assay in acute event triage and management
    • Victims with a potential whole-body dose in the range of 1.5-3 Gy
      • May be at risk for the ARS hematological subsyndrome.
      • May develop cytopenias about 21-28 days after exposure.
      • Dicentric Chromosome Assay may help identify persons who should be triaged to locate near a medical facility having expertise in managing pancytopenic patients.
    • Victims with potential whole-body doses >3 Gy
      • May become symptomatic and pancytopenic before the results of dicentric chromosome assay become available. Lymphocyte depletion kinetics are useful in this setting.
      • Nevertheless, Dicentric Chromosome Assay results could provide useful confirmatory information.
    • Risk assessment for carcinogenicity
  • What other chromosomal assays may be helpful?
    • Radiation-induced chromosomal translocations can be detected with the fluorescent in situ hybridization (FISH) technique as an alternative to the dicentric chromosome assay in specific circumstances 6
      • For retrospective dose assessment when blood is drawn long after the event (e.g., > 1 year), FISH is thought to be more accurate than the dicentric chromosome assay.
      • FISH measures cell division compatible translocations (symmetrical translocations).
      • Translocations in the stem cell population are transmitted through lymphopoiesis, ultimately appearing in the circulating pool of lymphocytes.
      • However, several confounding factors (including a high background incidence, variability among individuals, non specificity) make the FISH assay less attractive for acute radiation dose assessment.
    • See other techniques (including premature chromosome condensation (PCC) and the micronucleus assay) and detailed information in the references list 7-22
    • See excellent table comparing advantages and disadvantages of existing and developing techniques, including the dicentric chromosome assay, for assessment of radiation exposure levels. 23
  • Are there standards published for chromosomal assays for radiation dose assessment?
    • Cytogenetic Analysis for Radiation Dose Assessment: A Manual. (PDF - 859 KB) IAEA Technical Report Series No. 405, pp.127, Vienna, 2001
      NOTE: This document is currently being revised. A new document entitled "Radiation Protection-Performance Criteria for Service Laboratories Performing Cytogenetic Triage for Assessment of Mass Casualties in Radiological and Nuclear Emergencies."

top of page


Illustrations


Dicentric Chromosomes

Dicentric Chromosomes
Dicentric Chromosome

Notes on the graphs above:
  • Radiation exposure causes DNA strand breaks leading to abnormal chromosome replication, including dicentric chromosome formation. This figure illustrates the double-strand break.
  • Increases in radiation dose produce increasing numbers of aberrant (dicentric) chromosomes.
  • The number of dicentric chromosomes correlates well with radiation dose (i.e., increases in dose produce increased numbers of dicentric chromosomes).
Sources of data for the graph above:

Conventional Lymphocyte Metaphase-Dicentric Assay

Conventional Lymphocyte Metaphase-Dicentric Assay
Notes on the graph above:
  • Left panel: A schematic illustrating radiation-induced DNA damage (see left side of image) in an interphase cell and the resulting formation of radiation-induced dicentric (DIC) and accompanying acentric fragment (Ac) chromosome aberration in lymphocytes arrested in metaphase mitosis.

  • Right panel: Dose response relationship for dicentrics in human lymphocytes exposed to incremental radiation doses from three radiation qualities: 250 kVp x rays, fission neutrons, and Cobalt-60 gamma rays.
Sources of data for the graph above:


Scoring of Dicentrics

closeup of slide showing normal metaphase spread of 46 chromosomes closeup of slide showing a dicentric spread of 45 chromosomes
Image AImage B
Notes on the graphs above:
  • A digital photo of the metaphase spread is taken at 630x magnification.
  • A dicentric chromosome has two centromeres — the point where the two chromatids connect.
  • The number of dicentric chromosomes is counted and compared to calibration curves to estimate radiation dose.
  • Image A displays a normal metaphase spread.
  • Image B reveals a metaphase spread with a dicentric chromosome circled in red.
Sources of data for the graphs above:

top of page


References

  1. Prasanna PGS, Personal communication
  2. Walchuk M, Cytogenetic biodosimetry at the Armed Forces Radiobiology Research Institute, An interview with Dr. Pataje Prasanna, Health Physics News, XXXV(11), November 2007
  3. Prasanna PGS, Loats H, Gerstenberg HM, et al. AFRRI's gamma-ray, x-ray and fission-neutron calibration curves for the dicentric assay: Application of a metaphase finder system. (PDF - 309 KB) Fort Belvoir, VA, USA; AFRRI, Defense Technical Information Center, Fort Belvoir, VA, 2002
  4. Wilkins RC, Romm H, Kao TC, Awa AA, Yoshida MA, Livingston GK, Jenkins MS, Oestreicher U, Pellmar TC, Prasanna PG. Interlaboratory comparison of the dicentric chromosome assay for radiation biodosimetry in mass casualty events Radiat Res. 2008 May;169(5):551-60. [PubMed Citation]
  5. Prasanna PGS, Moroni M, Pellmar C, Triage dose assessment for partial-body exposure: Dicentric analysis, Health Physics, in press 2009.
  6. Fucic A, Zeljezic D, Kasuba V, Kopjar N, Rozgaj R, Lasan R, Mijic A, Hitrec V, Lucas JN. Stable and unstable chromosome aberrations measured after occupational exposure to ionizing radiation and ultrasound. Croat Med J. 2007 Jun;48(3):371-7. [PubMed Citation]
  7. Leonard A, Rueff J, Gerber GB, Leonard ED. Usefulness and limits of biological dosimetry based on cytogenetic methods. Radiat Prot Dosimetry. 2005;115(1-4):448-54. [PubMed Citation]
  8. Alexander GA, et al., BiodosEPR-2006 Meeting: Acute dosimetry consensus committee recommendations on biodosimetry applications in events involving uses of radiation by terrorists and radiation accidents. (PDF - 518 KB) Radiat Meas. 2007 July;42(6-7):972-96.
  9. Radiation Dosimetry Monograph: "Applications of Dosimetry in Radiation Epidemiology" (Radiation Research, July 2006, Volume 166, Number 1. Special Supplement) (HHS/National Cancer Institute/Division of Cancer Epidemiology and Genetics)
  10. Lloyd DC, Edwards AA, Moquet JE, Guerrero-Carbajal YC. The role of cytogenetics in early triage of radiation casualties. Appl Radiat Isot 2000 May;52(5):1107-12. [PubMed Citation]
  11. Introduction to radiation physics and dosimetry (PDF -4.67 MB) (Steven L. Simon, Radiation Epidemiology Course, May 2007, HHS/National Cancer Institute/Division of Cancer Epidemiology and Genetics)
  12. Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, Tsu H, Confer DL, Coleman CN, Seed T, Lowry P, Armitage JO, Dainiak N. Strategic National Stockpile Radiation Working Group. Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med. 2004 Jun 15;140(12):1037-51. [PubMed Citation]
  13. Sine RC, Levine IH, Jackson WE, Hawley AL, Prasanna PG, Grace MB, Goans RE, Greenhill RG, Blakely WF. Biodosimetry Assessment Tool: a post-exposure software application for management of radiation accidents. Mil Med. 2001 Dec;166(12 Suppl):85-7 [PubMed Citation]
  14. Goans RE, Holloway EC, Berger ME, Ricks RC. Early dose assessment in criticality accidents. Health Phys. 2001;81:446-9. [PubMed Citation]
  15. Bender MA, Gooch PC. Somatic chromosome aberrations induced by human whole-body irradiation: the "Recuplex" criticality accident. Radiat Res. 1966;29:568-82. [PubMed Citation]
  16. Prasanna PG, Escalada ND, Blakely WF. Induction of premature chromosome condensation by a phosphatase inhibitor and a protein kinase in unstimulated human peripheral blood lymphocytes: a simple and rapid technique to study chromosome aberrations using specific whole-chromosome DNA hybridization probes for biological dosimetry. Mutat Res 2000 Mar 23;466(2):131-41. [PubMed Citation]
  17. Blakely WF, Salter CA, Prasanna PGS. Early-response biological dosimetry-Recommended countermeasure enhancements for mass-casualty radiological incidents and terrorism. Health Phy 2005 89(5):494-504 [PubMed Citation]
  18. Prasanna PGS, Blakely WF. Premature chromosome condensation in human resting peripheral blood lymphocytes for chromosome aberration analysis using specific whole-chromosome DNA hybridization probes. 2005 Methods Mol boil 291:49-57 [PubMed Citation]
  19. Bauchinger M, Blakely WF, Darroudi F, Edwards A, Fenech M, Hayata I, Koteles GJ, Lindholm C, Lloyd D, Lucas J, Prasanna PGS, Roy L, Sorokine-Durm I, Turai I, Voisin P: Cytogenetic Analysis for Radiation Dose Assessment: A Manual. (PDF - 859 KB) IAEA Technical Report Series No. 405, pp.127, Vienna, 2001
  20. Dainiak N, Berger P, Albanese J. Relevance and feasibility of multi-parameter assessment for management of mass casualties from a radiological event. Exp Hematol. 2007 Apr;35(4 Suppl 1):17-23. [PubMed Citation]
  21. Chao NJ. Accidental or intentional exposure to ionizing radiation: biodosimetry and treatment options. Exp Hematol. 2007 Apr;35(4 Suppl 1):24-7. [PubMed Citation]
  22. Albanese J, Martens K, Karkanitsa LV, Dainiak N. Multivariate analysis of low-dose radiation-associated changes in cytokine gene expression profiles using microarray technology. Exp Hematol. 2007 Apr;35(4 Suppl 1):47-54. [PubMed Citation]
  23. High dose radiation effects and tissue injury, Report of the Independent Advisory Group on Ionising Radiation, page 41 (Health Protections Agency, UK)
  24. Wojcik A, Lloyd D, Romm H, Roy L. Biological dosimetry for triage of casualties in a large-scale radiological emergency: capacity of the EU member states. Radiat Prot Dosimetry. 2009 Dec 1. [Epub ahead of print] [PubMed Citation]

US Department of Health & Human Services     
U.S. Department of Health & Human Services Office of the Assistant Secretary for Preparedness and Response National Library of Medicine

DCSIMG